nbia-logo1

English French German Italian Spanish
Text Size

Grants Awarded

NBIA Disorders Association has funded 21 research grants since 2002, totaling $655,800. Grants are awarded to qualified researchers to initiate pilot studies, the results of which are intended to be used to obtain larger multi-year grant funding. Many of these grants have led to the discovery of NBIA genes and the development of mouse and fruit fly disease models.

We are now accepting letters of intent from interested researchers for our next grant cycle that are due by Oct. 31, 2013. Please see the Grant Application on the right side of this page for further details.

  • April 2012:  Tobias Haack, Ph.D., Helmholtz Center, Munich, Germany. “Next generation sequencing for disease gene identification and genetic testing in NBIA.” $40,000.
  • April 2012:  Ulrich Salzer, Ph.D., Medical University of Vienna, Vienna, Austria. “Type and frequency of acanthocytosis in PKAN patients and family members from the region of Cabral and possible links to neurodegeneration.” $25,000.
  • February 2012:  Roberta Leonardi, Ph.D., Dept of Infectious Diseases, St. Jude Children’s Hospital, Memphis, Tenn.  “An adeno-associated virus mediated mouse model for PKAN disease.” $30,000.
  • December 2011:  Arcangela Iuso, Ph.D., Institute of Human Genetics, Helmholtz Center, Munich, Germany.  “Development of cellular and drosophila models to characterize a newly identified NBIA gene.” $30,800.
  • December 2011:  Ody C.M. Sibon, Ph.D., University Medical Center, Groningen, Netherlands. “Investigating the potential of specific pantethine derivatives to treat PKAN.” $40,000.
  • December 2011:  Paul Kotzbauer, M.D., Ph.D., Washington University, St. Louis MO.  “Therapeutic approaches to increase Acyl Coenzyme A production in Neurodegeneration with Brain Iron Accumulation.” $40,000.
  • February 2010:  Lars Timmerman, M.D., Ph.D. & Amande Pauls, M.D., Ph.D., University of Cologne, Cologne Germany. “Stimulation of the Globus pallidus internus in patients with NBIA: prospective analysis of international therapeutic outcomes and development of a therapeutic algorithm.” $30,000.
  • November 2009:  Michael Kruer, M.D., Oregon Health & Science University, Portland OR. “SNP microarray-based disease gene discovery in idiopathic NBIA.” $30,000.
  • November 2008:  Ody C.M. Sibon, Ph.D., University Medical Center, Groningen, Netherlands. “Investigating the potential of pantethine to rescue pantothenate kinase deficiency.” $30,000.
  • November 2008:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Proteomic Analysis of Neuroaxonal Spheroids.” $30,000.
  • December 2007:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Towards clinical therapeutics in PKAN.” $30,000.
  • December 2007:  Paul Kotzbauer, M.D., Ph.D., Washington University, St. Louis MO.   “Combined disruption of mouse PANK2 and PLA2G6 genes to generate an improved animal model of NBIA.” $30,000.
  • December 2007:  Soma Das, Ph.D., University of Chicago, Chicago IL. “Deletion and duplication analysis of the PANK2 and PLA2G6 genes in patients with NBIA.” $30,000.
  • December 2006:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “The molecular pathogenesis of NBIA.” $30,000.
  • December 2005:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Dynamics in brain iron distribution in PKAN.” $30,000.
  • October 2004:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “New gene discovery in NBIA.” $30,000.
  • September 2003:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “Toward rational therapies for PKAN.” $30,000.
  • September 2003:  Natalie Canham, M.B., University of Birmingham, Birmingham U.K. “Identification of the gene responsible for autosomal recessive NBIA and Congenital Cerebellar Hypoplasia.”       $30,000.
  • September 2002:  Penelope Hogarth, M.D., Oregon Health & Science University, Portland OR. “Clinical outcome measures in Hallevorden-Spatz Syndrome.”  $30,000.
  • September 2002:  Susan Hayflick, M.D., Oregon Health & Science University, Portland OR. “The biochemical basis for Hallevorden-Spatz Syndrome.” $30,000.
  • September 2002:  Han-Xiang Deng, M.D., Ph.D., Northwestern University Medical School, Chicago, IL. “Development of a mouse model of Hallevorden-Spatz Syndrome.”  $30,000.